Infusion Pump Market To Reach $16.3 Billion by 2035

Infusion pump market is projected to grow from $8.7 billion in 2025 to $16.3 billion by 2035, registering a CAGR of 6.5% during the forecast period. The market growth is primarily driven by the increasing prevalence of chronic diseases, rising demand for precision drug delivery, and the expansion of home-based healthcare systems globally. A key macro driver accelerating market growth is the rising global burden of diabetes, which directly fuels demand for infusion pumps, particularly insulin pumps. According to the World Health Organization, approximately $422 million people globally are living with diabetes, with the majority residing in low- and middle-income countries. Additionally, the International Diabetes Federation estimates that this number could rise to $643 million by 2030, significantly increasing the need for continuous insulin delivery systems. This surge in patient population is directly translating into higher adoption of infusion pumps, especially in home care settings where automated and wearable devices are preferred.

Browse the full report description of “Infusion Pump Market Size, Share & Trends Analysis Report, By Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps), By Technology (Traditional Infusion Pumps, Smart Infusion Pumps, Wireless/Connected Infusion Pumps), By Application (Oncology, Diabetes Management, Pain Management, Gastroenterology, Pediatrics & Neonatology, Hematology), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/infusion-pump-market

Among product segments, Insulin Pumps are witnessing the fastest growth due to their integration with smart technologies and increasing adoption among diabetic patients. The shift toward connected and wearable infusion systems is further enhancing patient compliance and treatment outcomes. The U.S. Food and Drug Administration has also accelerated approvals for advanced insulin delivery devices, supporting rapid commercialization and adoption. Manufacturers are actively implementing strategic initiatives to capitalize on this high-growth segment. In 2023, Insulet Corporation expanded its Omnipod 5 automated insulin delivery system into international markets, strengthening its global footprint. In 2024, Medtronic plc received expanded regulatory clearance for its MiniMed systems in Europe, boosting adoption in advanced healthcare markets.

Market players are actively implementing strategic initiatives to strengthen their positions. A few of the strategies are given below: -

• In Aug 2025, Terumo India launched Terufusion advanced infusion systems targeting ICU settings.

• In December 2023, Fresenius Kabi signed a landmark multi-year agreement with the Mayo Clinic to deploy 10,000 Ivenix Large-Volume Infusion Pumps across its facilities.This partnership underscores the market's shift toward "smartphone-like" user interfaces and adaptive pumping technology that maintains accuracy regardless of bag height or fluid viscosity—addressing long-standing "gravity-dependency" issues in traditional pumps.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Product Type
  • Technology
  • Application
  • End User
  • Competitive Landscape – Becton, Dickinson and Company (BD), Baxter International Inc., IC Medical, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Infusion Pump Market Report Segment

By Product Type

• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Insulin Pumps
• Enteral Infusion Pumps
• Implantable Infusion Pumps

By Technology

• Traditional Infusion Pumps
• Smart Infusion Pumps (Dose Error Reduction Systems - DERS)
• Wireless/Connected Infusion Pumps

By Application

• Oncology
• Diabetes Management
• Pain Management
• Gastroenterology (Enteral Nutrition)
• Pediatrics & Neonatology
• Hematology (e.g., chemotherapy, transfusion support)

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Specialty Clinics

Global Infusion Pump Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/infusion-pump-market